B02A Antifibrinolytics
ATC group of level 3 – pharmacological subgroup · in plain English: medicines to stop bleeding
This site has the patient leaflet or the SPC of 15 medicines in this group and its subgroups.
- 7 prescription only (POM)
- 1 with or without a prescription, by the pack
- 2 no longer supplied or not available
Place in the ATC classification
- B Blood and blood forming organ drugs 1,013 medicines
- B02 Antihemorrhagics 196 medicines
-
B02A Antifibrinolytics 15 medicines
- B02AA Antifibrinolytic amino acids 13 medicines
- B02AB Proteinase inhibitors, antifibrinolytic 2 medicines
-
B02A Antifibrinolytics 15 medicines
- B02 Antihemorrhagics 196 medicines
Active substances in the group
- Human alpha1-proteinase inhibitor 1 medicine
- Tranexamic acid 13 medicines
Medicines in the group and its subgroups
Other groups of the same level
- B02B Vitamin K and other hemostatics 180 medicines
Other names of the ATC group
- Czech: B02A Antifibrinolytika
- French: B02A antifibrinolytiques
- German: B02A ANTIFIBRINOLYTIKA
- Spanish: B02A ANTIFIBRINOLITICOS
- German: B02A ANTIFIBRINOLYTIKA
- Italian: B02A ANTIFIBRINOLITICI
- Polish: B02A Leki antyfibrynolityczne
- Turkish: B02A ANTİFİBRİNOLİTİKLER
- Portuguese (Brazil): B02A ANTI-FIBRINOLÍTICOS
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group B02A
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
